Zobrazeno 1 - 10
of 49
pro vyhledávání: '"H. Moha Ou Maati"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 12:224
Introduction Myocardial infarction leads to a loss of cardiac tissue, which is then replaced by fibrosis. Following this loss in adult mammals, pathological hypertrophy takes place and leads to heart failure. Zebrafish are able to regenerate their he
Autor:
Sébastien Moreno, Jean Mazella, A Khayachi, Marc Borsotto, Stéphane Martin, H. Moha Ou Maati, Morgane Roulot, Christelle Devader, J. Veyssiere, Catherine Heurteaux
Publikováno v:
British Journal of Pharmacology. 172:2604-2617
Background and Purpose We have described a novel antidepressant peptide, spadin, that acts by blocking the TWIK-related-potassium channel, type 1 (TREK-1). Here, we examined possible mechanisms of action of spadin at both molecular and cellular level
Autor:
Jean Mazella, Marc Borsotto, H. Moha Ou Maati, Catherine Heurteaux, Christelle Devader, J. Veyssiere
Publikováno v:
British Journal of Pharmacology. 172:771-784
Depression is a disease that is particularly frequent, affecting up to 20% of the population in Western countries. The origins of this pathology involve multiple genes as well as environmental and developmental factors leading to a disorder that rema
Autor:
Hervé Quintard, J. Veyssiere, H. Moha Ou Maati, C. Gandin, B. Onteniente, Catherine Heurteaux, M Lazdunski, Marc Borsotto, Catherine Widmann
Publikováno v:
Cerebrovascular Diseases. 35:1-7
Background: Treatments for stroke and other brain injuries are limited. NeuroAiD has been shown to be beneficial in clinical studies. We reviewed the pharmacological effects of NeuroAiD on the normal and ischemic brain and neurons. Methods: In vivo a
Autor:
M. Martínez-Cutillas, Víctor Gil, D. Gallego, Marcel Jiménez, Catherine Heurteaux, Marc Borsotto, Rémi Peyronnet, H. Moha Ou Maati
Publikováno v:
AJP-Gastrointestinal and Liver Physiology
AJP-Gastrointestinal and Liver Physiology, American Physiological Society, 2012, 303 (3), pp.G412-23. ⟨10.1152/ajpgi.00040.2012⟩
AJP-Gastrointestinal and Liver Physiology, American Physiological Society, 2012, 303 (3), pp.G412-23. ⟨10.1152/ajpgi.00040.2012⟩
Purinergic and nitrergic neurotransmission predominantly mediate inhibitory neuromuscular transmission in the rat colon. We studied the sensitivity of both purinergic and nitrergic pathways to spadin, a TWIK-related potassium channel 1 (TREK1) inhibi
Autor:
Patrick Bois, Olivier Stucker, Elisabeth Laemmel, Jean François Faivre, Stephen G. Dilly, Stephanie Guilbot, M Le Grand, Catherine Pons-Himbert, Joffrey Ducroq, H Moha ou Maati
Publikováno v:
British Journal of Pharmacology. 159:93-101
Introduction: Doxorubicin, an anthracycline widely used in the treatment of a broad range of tumours, causes acute QT prolongation. Dexrazoxane has been shown to prevent the QT prolongation induced by another anthracycline, epirubicin, but has not ye
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 9:166
Autor:
C, Devader, A, Khayachi, J, Veyssière, H, Moha Ou Maati, M, Roulot, S, Moreno, M, Borsotto, S, Martin, C, Heurteaux, J, Mazella
Publikováno v:
British journal of pharmacology. 172(10)
We have described a novel antidepressant peptide, spadin, that acts by blocking the TWIK-related-potassium channel, type 1 (TREK-1). Here, we examined possible mechanisms of action of spadin at both molecular and cellular levels.Effects of spadin wer